N
Google TrendMAX CASTER (200+) — Moose Def. Max Caster At TNA Bound For Glory 2026
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:max caster200+prince harry family photo story200+kelley knockel500+torino vs udinese200+coventry vs newcastle5000+levante - sevilla2000+servicio de control de inmigración y aduanas1000+indigo girls500+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "BlueWind Medical Secures" (9 stories)

Top Headline Story

BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
Lead StoryBusiness Wiregeneral
May 14

BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System

<a href="https://news.google.com/rss/articles/CBMi6gFBVV95cUxON3JBcmVxY0lZUHNxX05DZTB0N2MxZ21Fa2pUeWxVU3R3dXhZcXBkNUNpaVktOHBESE1ET2VSaUppTGFDZ2VjcWxRaVl6OHRlMmczdm52OXp2NGlfOE9rSmN5c1VVNi1RMmVfeUhBeW4xYmUyZXgweTFqdmNOWjBySjZ2b2NhMTJfczNzWEpPa210cEk5aFlRY0dkYnR6ZVFhRUFhUGRHR1NiajBEd09pSVVSZUdEaVVidm1maWVwSDVOelNpZkpORlQ3V3lsYUc0SXdWNDA1WmE3c0xTWFhOV1ZRRkFKcV9kdnc?oc=5" target="_blank">BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
200+18m ago

max caster

Moose Def. Max Caster At TNA Bound For Glory 2026

Filter stories
200+18m ago

prince harry family photo story

Prince Harry Reveals the Photo He Took of Archie and Lilibet That ‘Fills My Heart’

Filter stories
500+28m ago

kelley knockel

1 dead, multiple injured after pair of motorcycle crashes involving deer in Iowa

Filter stories
200+28m ago

torino vs udinese

Torino vs Udinese: Italian Serie A stats & head-to-head

Filter stories

Search Results for "BlueWind Medical Secures"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

8 stories displayed
BlueWind Medical: $47.8 Million Funding Raised To Accelerate Commercialization Of Revi System
Pulse 2.0tech

BlueWind Medical: $47.8 Million Funding Raised To Accelerate Commercialization Of Revi System

<a href="https://news.google.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?oc=5" target="_blank">BlueWind Medical: $47.8 Million Funding Raised To Accelerate Commercialization Of Revi System</a>  <font color="#6f6f6f">Pulse 2.0</font>

Read Full StoryMore like this
BlueWind Medical Receives FDA 510(k) Clearance for Enhanced Revi® Wearable Supporting Long-Term Treatment of Urgency Urinary Incontinence
Business Wiregeneral

BlueWind Medical Receives FDA 510(k) Clearance for Enhanced Revi® Wearable Supporting Long-Term Treatment of Urgency Urinary Incontinence

<a href="https://news.google.com/rss/articles/CBMimwJBVV95cUxQWnVxMmlSTmc2MEhUYUFOU1A3eTlOVF9walRXemw4WV9FOHJlOVBCWGlYOFBtYXdGWmUyeG5jTE1aVVRZVkxIRDB4bklENmplSFRpRENGSVNTMXRyRktqLU04U3hmRDFWd0tnUW5xZHlvMHhjUUN5UlE3YkNnSlE0ZTE2NjhOQXdGTmVBUm9QbTktbnJ5aFBNeW15OTJ6QlR3U0s5bmIyejlKcWtmZGxxdWZHa2tyR3pTWjNMRlNERzlDRTl6SmhqNmZHU293Sk5BVFRab09wTnRLY0hiRFFUU1FRYzhQcExQeE94MmRUQVJWOUpkMHIyeVZkR29Pc2x0X1NwTDViWGczcGl4NzFmUW42WGhuTVJZMVJz?oc=5" target="_blank">BlueWind Medical Receives FDA 510(k) Clearance for Enhanced Revi® Wearable Supporting Long-Term Treatment of Urgency Urinary Incontinence</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Roger Dmochowski, MD, on quality-of-life outcomes with the Revi System
Urology Timesgeneral

Roger Dmochowski, MD, on quality-of-life outcomes with the Revi System

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxPTWxnRXZxcENpdTVId3RSTkdxdFY0R1YzT1NUdTdod2N5UW82amFIXzdISmFxVExrT1lFTnFzQi1meUVxNVFBQVhNdXFETnlvYUQ0ak15T3UxblFNMG9CQXRoV3FrQVVuMlZCYmNoeTZIQnd5d21KY2xpQml4UWEwaHk1RDhaaFlpaEE5SURnQ0RGODJpMFpDQ2E0czBEUFU1cUVTUw?oc=5" target="_blank">Roger Dmochowski, MD, on quality-of-life outcomes with the Revi System</a>  <font color="#6f6f6f">Urology Times</font>

Read Full StoryMore like this
Medtronic secures FDA approval for Altaviva device for urinary incontinence
Med-Tech Insightsgeneral

Medtronic secures FDA approval for Altaviva device for urinary incontinence

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxPaFhpQ3N4a3MtaHdkS01kMkx5QmVaM1l3MzJrMnFBNVJMSU9lM1hySW1BNFZQNC05b0xiTXJjRGRSaWwycWJGOUgzRFp6bk1oYWRYSHNfLTZUYjRPU3pjOUNtTzFwYWtnVUJnZ19wYWRIamJxeG9yUVVGUERsVUFIUHQyaDB0UmtSbjNyYjJlV01oNTVaYXc?oc=5" target="_blank">Medtronic secures FDA approval for Altaviva device for urinary incontinence</a>  <font color="#6f6f6f">Med-Tech Insights</font>

Read Full StoryMore like this
BlueWind Medical's Revitm System Secures U.S. FDA De Novo Classification Grant for the Treatment of Urgency Incontinence
Lelezardgeneral

BlueWind Medical's Revitm System Secures U.S. FDA De Novo Classification Grant for the Treatment of Urgency Incontinence

<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxObGlMMnpON3NrTVVYS2UwdGJ4MmhyeEZmczAtVzVzWTVZX0pidHN5MTAwdG5OVll2VkowMWZjWGFtWUVfMzJ2b2dueUtBZUZXdVFhdVhQbXFPdkduMU5Ja085NU1PSzhNSWM0RldQNzRDZTJ1aVBXclQ1SjBWUWVZcUZTUC1IZU9YZHRDZThQV2pDNDE0eGN1WU10TEZUWl9mbEJmQzV0eHpSNUd6b2h1NGI0YXZoRTk4R2NvVWtWQlFfZUFVNXN1bzJ5S0poVDk0SDJLN0dqU29mYUxS?oc=5" target="_blank">BlueWind Medical's Revitm System Secures U.S. FDA De Novo Classification Grant for the Treatment of Urgency Incontinence</a>  <font color="#6f6f6f">Lelezard</font>

Read Full StoryMore like this
BlueWind Medical Receives FDA 510(k) Clearance for Revi® Extend Implant
Business Wiregeneral

BlueWind Medical Receives FDA 510(k) Clearance for Revi® Extend Implant

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxQdXVRRzBYRnh5cjZITmlIZU9rd2tpelQ5QnJEQXlvQ2ZpOWttdm9NVkRRaVVnTjlsTGRPTlpqRTRYOVFVNVNJV3Q2NkRiOHJlZnJKSkIwZ2R1VWRialdrS3Y4WGpPOTJwVDBYbzRsdllvU2hoZUdvaDdQMmV0cXRZYklwNkdSRkQzV01lMEQ4X2lUaFotM1AwQlM2SW9jOTBjd3oteVRRRlFlUTlQVTBPYnJpN2g5UHgzRmVCZmxPelU5bFk?oc=5" target="_blank">BlueWind Medical Receives FDA 510(k) Clearance for Revi® Extend Implant</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
FDA grants De Novo marketing approval to Revi System for urge urinary incontinence
Urology Timesmarkets

FDA grants De Novo marketing approval to Revi System for urge urinary incontinence

<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxPUmo5X0xjX3pleWpBcFIwRnpKQlkzYUw4dmRRQVBkVC1iMnVNN1B4YVRYTVc2STNvaVN0alk4TWRfa3cwSmpwQmM0VUMtc3BZMFVwTU0tVnluLWtXSmh1TVh1NERVWTNDaFlPOUZwdE1RdzM1bkxhbzRzelFsbHpaWFVXU3VzZF9HTkdQSU9JZldiQW1UZTBFV0ZpaDBndnNMZFE0YWFHNGJEc3FOV1NXb0Jsaw?oc=5" target="_blank">FDA grants De Novo marketing approval to Revi System for urge urinary incontinence</a>  <font color="#6f6f6f">Urology Times</font>

Read Full StoryMore like this
Three-Year Data Reinforce Revi® System as the Most Clinically Validated Implantable Tibial Neuromodulation Therapy for Urgency Urinary Incontinence
Business Wiregeneral

Three-Year Data Reinforce Revi® System as the Most Clinically Validated Implantable Tibial Neuromodulation Therapy for Urgency Urinary Incontinence

<a href="https://news.google.com/rss/articles/CBMiqwJBVV95cUxOR0xCUE5WRVdXeVJsQkQ0WHJfTHZ4U1huZ2g2RS1HeEZlSzVmZHl4LTJnYnBUSUVCWnJUWWE5RjNfV0F0eHl4bDc2N2ZuZzFJU3FxS0RtY2gtaTRlZnoxRy13OElweWdtZTEycU9RTXVqMHlTYmNpdWFtRnpqcUxwNFE4NGxMRElxUEU1ckhrUmJ6dDJ3TlBMb0x6Zms5bkh3OW5RX0ZVa0dmeHJOb2JLWm5BdnNjcFpFTzRnRUJ0MlZvRzN3aUFaYVUzcTVXOFZwU1VLM2ZMVUhQU1puZzF0ZEpkY1RxQmVlWnJPeUZIYlBfdlFPOW43bTVkd2cxSlE3Q01sdFcwUWFxX3VRY3BKaWlwU09HMXNpbWNNeE9vUGFkV3B1UzBFSkxWdw?oc=5" target="_blank">Three-Year Data Reinforce Revi® System as the Most Clinically Validated Implantable Tibial Neuromodulation Therapy for Urgency Urinary Incontinence</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
"BlueWind Medical Secures" — Live Google News Trends & Headlines